Comment on "2025 Taiwan guidelines on the drug therapy of lung cancer: Advanced non-squamous cell carcinoma with actionable oncogenic drivers" [0.03%]
关于《2025台湾肺癌药物治疗指南：驱动基因阳性晚期非鳞状细胞癌》的评论
Suresh Babu Sayana
Suresh Babu Sayana
The unmeasured role of concomitant medication dynamics and immortal time bias in SGLT2 inhibitors study [0.03%]
SGLT2抑制剂研究中伴发病药物变化及长生不朽时间偏倚的未测量作用
Zhibo Jia,Menglong Li
Zhibo Jia
Reply to comment on "Further considerations on the incremental value of CONUT score in surgically treated head and neck cancer" [0.03%]
有关“头颈部癌症手术治疗中CONUT评分增量价值的进一步考虑”的评论回复
Ming-Hsien Tsai,Chih-Yen Chien,Fu-Min Fang
Ming-Hsien Tsai
Comment on "Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy" [0.03%]
关于“使用99mTc-PYP SPECT/CT监测RNA干扰治疗在遗传性转甲状腺素蛋白淀粉样变心肌病患者中疗效的改变”的评论
Safoyev Baqodir Barnoyevich,Nurboboyev Adham Uyg Unovich,Safoyev Bobur Baqodirovich
Safoyev Baqodir Barnoyevich
Comment on "Analysis of risk factors and development of a prediction model for acute kidney injury in elderly patients after abdominal surgery" [0.03%]
对《老年患者腹腔手术后急性肾损伤风险因素分析及预测模型构建》一文的评论
Jie Gao,Hongquan Liu,Yingxin Shi et al.
Jie Gao et al.
Comment on "Deep brain stimulation and magnetic resonance-guided focused ultrasound in Parkinsonism and related disorders: State-of-the-Art and future prospects" [0.03%]
关于“帕金森病及其他运动障碍的治疗：现状与前景”的评论
R Gayathri,Prasad Babu Bairysetti,Anandakumar Haldorai
R Gayathri
Comment on "Development and validation of machine learning models for mortality risk stratification in acute pancreatitis patients complicated by acute kidney injury" [0.03%]
关于“急性胰腺炎合并急性肾损伤患者死亡风险分层的机器学习模型的开发与验证”的评论
Nilesh T Deotale,K Naresh Babu,Thota Radha Rajesh
Nilesh T Deotale